Status:

WITHDRAWN

Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs

Lead Sponsor:

Azidus Brasil

Conditions:

Chronic Renal Failure

Eligibility:

All Genders

14-65 years

Phase:

PHASE3

Brief Summary

Prove the efficacy of pancreatic enzyme Norzyme ® imported by Pharmaceutical Chemistry Laboratory Bergamo Ltda. verified by activity lipase contained in the formulation in controlling steatorrhea in 1...

Detailed Description

Phase III clinical trial systematic sampling, double-blind, randomized, crossed that evaluates the comparative efficacy of a formulation containing enzyme pancreas in 16 patients with pancreatic insuf...

Eligibility Criteria

Inclusion

  • nclusion Criteria:
  • Research subjects aged between 14 and 65 years of both sexes;
  • Exogenous pancreatic insufficiency of any etiology;
  • Subjects who do not regularly use or pancreatic enzymes by orally;
  • Freely agree to sign the consent form and clarified before all the essential elements of the protocol be clarified before any procedure.
  • Exclusion Criteria:
  • Participation in any study or have ingested some experimental drug trial in the 3 months preceding the study.
  • Regular use of medication that interferes with the action of the drug test:
  • in the 4 weeks preceding the study or make use of any medications that interfere with drug test a week before the start the study.
  • Patients who take any kind of treatment for morbid obesity.
  • Cases of stomach reduction surgery.
  • Cases of surgical reduction of the intestine.
  • Present history of current abuse of alcohol or have drunk alcohol in the 48 hours prior to the study.
  • Have any condition which prevents him from participating in the study, for trial Principal Investigator.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2011

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT01228643

    Start Date

    June 1 2007

    End Date

    December 1 2011

    Last Update

    November 3 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    LAL Clinica Pesquisa e Desenvolvimento LTDA

    Valinhos, São Paulo, Brazil, 13271000